Register now to R3i !
Your Login
Your Password
Confirm Password  
Your Email

RECENT PUBLICATIONS ON RESIDUAL RISK

2018

Cost of diabetic complications in Germany

This new study underlines the economic impact of complications of type 2 diabetes in Germany, based on nationwide data from316,220 patients. Both cardiovascular and microvascular complications were associated with significant cost to the healthcare system, both in the short- and long-term. Specifically, estimated costs (in the 3 months subsequent to the event) were:
diabetic foot €1,293, amputation €14,284, retinopathy €671, blindness €2,933, nephropathy €3,353, end-stage renal disease (ESRD) €22,691, nonfatal stroke €9,769, fatal stroke €11,176, nonfatal myocardial infarction (MI)/cardiac arrest (CA) €8,035, fatal MI/CA €8,700, nonfatal ischemic heart disease (IHD) €6,548, fatal IHD €20,942, chronic heart failure €3,912, and angina pectoris €2,695. In the subsequent quarters, costs ranged from €681 for retinopathy to €6,130 for ESRD.
 
These data highlight the need for early intervention to prevent the debilitating consequences of complications of type 2 diabetes.
Health care costs associated with incident complications in patients with type 2 diabetes in Germany.

Kähm K, Laxy M, Schneider U et al.